For the quarter ending 2026-03-31, FBLG has $5,938K in assets. $3,338K in debts. $1,482K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,482 | 4,894 | 4,867 | 8,845 |
| Prepaid expenses | 1,020 | 1,455 | 373 | 1,333 |
| Other current assets | 403 | 0 | - | - |
| Total current assets | 2,905 | 6,349 | 5,240 | 10,178 |
| Total property and equipment at cost | 1,290 | 1,290 | 1,290 | - |
| Less accumulated depreciation | 514 | 448 | 382 | - |
| Property and equipment, net | 776 | 842 | 908 | 967 |
| Operating lease right-of-use asset, net | 2,209 | 2,380 | 2,548 | 2,714 |
| Other assets | 48 | 48 | 48 | 48 |
| Total assets | 5,938 | 9,619 | 8,744 | 13,907 |
| Short-term convertible debt | - | 0 | 4,573 | 8,066 |
| Accounts payable and accrued expenses | 850 | 945 | 1,069 | 1,801 |
| Operating lease liability, short-term | 723 | 706 | 643 | 627 |
| Loan payable | 246 | - | - | - |
| Sepa put option liability | 10 | 108 | 437 | 470 |
| Total current liabilities | 1,829 | 1,759 | 6,722 | 10,964 |
| Operating lease liability, long-term | 1,509 | 1,704 | 1,897 | 2,083 |
| Total liabilities | 3,338 | 3,463 | 8,619 | 13,047 |
| Preferred stock, value | 0 | 0 | - | 0 |
| Voting common stock, 0.00001 par value 300,000,000 shares authorized as of march 31, 2026 and december 31, 2025 3,513,187 shares and 3,325,986 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 1 | 1 | - | - |
| Additional paid-in capital | 61,763 | 60,319 | 51,045 | 46,002 |
| Accumulated deficit | -59,164 | -54,164 | -50,920 | -45,142 |
| Total stockholders equity | 2,600 | 6,156 | 125 | 860 |
| Total liabilities and stockholders equity | 5,938 | 9,619 | 8,744 | 13,907 |
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG)